NAtional TUnisian REgistry of Heart Failure
- Conditions
- Heart Failure
- Registration Number
- NCT03262675
- Lead Sponsor
- Dacima Consulting
- Brief Summary
NATURE-HF is an observational, multicentric and longitudinal study of heart failure performed with 100 tunisian cardiologists.
- Detailed Description
The NATURE-HF is a national clinical non-interventional registry of heart failure, carried out in Tunisia at cardiology departments in hospitals and in liberal cardiology consultations. 100 cardiologists participate in the enrollment of the eligible patients as investigators. A Committee of Experts validates the protocol methodology and supervises the data-management. A Steering Committee helps investigators to monitor their patient inclusions, performs audit trails and prepares the statistical analysis plan for the study.
Collected data are managed by the DACIMA Clinical Suite®, the electronic data capture platform which complies with the FDA 21 CFR part 11 requirements (Food and Drug Administration 21 Code of Federal Regulations part 11), the HIPAA specifications (Health Insurance Portability and Accountability Act), and the ICH standards (International Conference on Harmonisation).
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 2040
- Patient with chronic heart failure
- Patient with acute heart failure (new onset or not)
- The diagnosis of heart failure is at the discretion of the investigator
- Informed and signed consent
- Life expectancy <12 months for extra cardiac disease
- Isolated Right Heart Failure
- Pregnant woman
- Renal failure with creatinine clearance < 15 ml / min
- Hemodialysis patients
- Cardiac surgery planned within 3 months
- Congenital heart disease
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cardiovascular death Time-To-Event measure up to 12 months from baseline Incidence of cardiovascular death including sudden death, death from refractory heart failure and death from stroke
- Secondary Outcome Measures
Name Time Method Global Death Time-To-Event measure up to 12 months from baseline Incidence of death of all causes (cardiovascular death and non-cardiovascular death)
Heart Failure Readmission At 1, 3 and 12 months from patient enrollment Incidence of heart failure readmissions
Trial Locations
- Locations (1)
Société Tunisienne de Cardiologie & de Chirurgie Cardio-Vasculaire
🇹🇳Tunis, Tunisie, Tunisia
Société Tunisienne de Cardiologie & de Chirurgie Cardio-Vasculaire🇹🇳Tunis, Tunisie, Tunisia